Biotech Fund Flanders Founded 1994
Portfolio analytics
News & Media
Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Rounds per year 0.22
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Health Care

In 1994 was created Biotech Fund Flanders, which is appeared as VC. The fund was located in Europe if to be more exact in Belgium. The leading representative office of defined VC is situated in the Antwerp.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Biotech Fund Flanders, startups are often financed by Gimv, Sofinnova Partners, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Sofinnova Partners. In the next rounds fund is usually obtained by Gimv, MP Healthcare Venture Management, Kempen & Co.

We can highlight the next thriving fund investment areas, such as Biopharma, E-Commerce. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Diatos, Pronota, Devgen. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.

This Biotech Fund Flanders works on 14 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Health Care
Health Diagnostics
Late Stage Venture
4M20 Jan 2012 Belgium, Ghent
Health Care
Health Diagnostics
Early Stage Venture
7M29 Jun 2009 Belgium, Ghent
Late Stage Venture
12M03 Jul 2007 France, Paris
Clinical Trials
Venture - Series Unknown
20M08 Feb 2007 Belgium, Ghent
Late Stage Venture
50M23 Aug 2006
Early Stage Venture
30M06 Apr 2004
Mobile Apps
Early Stage Venture
23M01 Oct 1999 Togo, Lomé
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biotech Fund Flanders?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: